Logo

Career Path of Laura Roe from the FDA - Shared screen with speaker view
Philippe
28:45
If you are allowed to share, how/what are you looking into the EHRs and how do you standardize that info between the programs?
Anita
29:34
Hi Laura, What courses or skills acquired from MMCi program help you in your current position?
Katie Kippley
29:34
Thank you so much for sharing your story and experiences Laura! What were the most valuable lessons or themes you learned while in the MMCI program that you brought into your new role? Or what was the most impactful class that you had in the program that increased the quality of work you were doing in previous or your current role?
Anita
32:05
Since COVID vaccine was developed in the shortest time what kind of tools does FDA use to project effectiveness and population penetration?
Anita
32:29
across various population groups
Anita
36:01
Is artificial intelligence used to evaluate past evidence to project future effectiveness of vaccines or possible therapeutics being developed?
Allen Coleman
44:09
Thank you, Laura, for sharing. This was very informative and applying at the FDA level for public health. -Allen
mingwei chen
48:43
Thanks!
Anita
49:04
Thanks for a wonderful presentation of the role of FDA
Alok Sahgal
49:08
Thank you Laura for sharing. Very helpful and informative talk.
Philippe
49:14
Thanks